Complete Genome Sequence of Neonatal Clinical Group B Streptococcal Isolate CJB111

Brady L Spencer; Anushila Chatterjee; Breck A Duerkop; Carol J Baker; Kelly S Doran

doi:10.1128/MRA.01268-20

Complete Genome Sequence of Neonatal Clinical Group B Streptococcal Isolate CJB111

Microbiol Resour Announc. 2021 Jan 14;10(2):e01268-20. doi: 10.1128/MRA.01268-20.

Authors

Brady L Spencer¹, Anushila Chatterjee¹, Breck A Duerkop¹, Carol J Baker^{2

3}, Kelly S Doran⁴

Affiliations

¹ Department of Immunology and Microbiology, School of Medicine, University of Colorado-Anschutz Medical Center, Aurora, Colorado, USA.
² Department of Pediatrics, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.
³ Children's Memorial Hermann Hospital, Houston, Texas, USA.
⁴ Department of Immunology and Microbiology, School of Medicine, University of Colorado-Anschutz Medical Center, Aurora, Colorado, USA [email protected].

Abstract

Group B Streptococcus (GBS) is an asymptomatic colonizer of the female reproductive tract but can cause maternal and neonatal infections and adverse pregnancy outcomes. Here, we closed the genome sequence of strain CJB111, a neonatal GBS clinical isolate from a case of late-onset bacteremia without focus (Houston, TX; 1990).

Abstract

Grants and funding